Literature DB >> 28666370

Assessment of HIV Screening Tests for Use in Preexposure Prophylaxis Programs.

Constance Delaugerre1,2, Guillemette Antoni3, Nadia Mahjoub1,2, Gilles Pialoux4, Eric Cua5, Armelle Pasquet6, Nolwenn Hall7, Cécile Tremblay8, Laurent Cotte9, Catherine Capitant3, Marie-Laure Chaix1,2,10, Laurence Meyer11,3, Jean-Michel Molina12,2.   

Abstract

Preexposure prophylaxis programs involve frequent human immunodeficiency virus (HIV) testing. We evaluated the sensitivity of 2 antigen/antibody immunoassays (Architect and Bioplex), 2 antibody-based rapid tests (Vikia-HIV-1/2 and Autotest-VIH), and 1 antigen/antibody rapid test (Alere HIV Combo) for the diagnosis of HIV infection. Among the 31 HIV-1-infected participants in the ANRS-IPERGAY trial, HIV-1 RNA was detected alone in only 2. The sensitivities of the Architect and Bioplex assays were 83% (95% confidence interval [CI], 76%-99%) and 82% (95% CI, 63%-94%), respectively. The sensitivities of the Vikia, Autotest, and Alere tests were 54% (95% CI, 34%-72%), 50% (95% CI, 31%-69%), and 78% (95% CI, 58%-91%), respectively. Antigen/antibody tests should be preferred to avoid missing cases of acute HIV infection and to decrease the related risks of viral transmission and emergence of drug resistance.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV diagnosis; HIV-1; HIV-1 RNA; PrEP; acute infection; antigen/antibody test; rapid test; recent infection

Mesh:

Substances:

Year:  2017        PMID: 28666370     DOI: 10.1093/infdis/jix297

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  HIV Pre-Exposure Prophylaxis Implementation Cascade Among Health Care Professionals in the United States: Implications from a Systematic Review and Meta-Analysis.

Authors:  Chen Zhang; James McMahon; Kevin Fiscella; Sarahmona Przybyla; Amy Braksmajer; Natalie LeBlanc; Yu Liu
Journal:  AIDS Patient Care STDS       Date:  2019-12       Impact factor: 5.078

Review 2.  Initiation, discontinuation, and restarting HIV pre-exposure prophylaxis: ongoing implementation strategies.

Authors:  Sarah E Rutstein; Dawn K Smith; Shona Dalal; Rachel C Baggaley; Myron S Cohen
Journal:  Lancet HIV       Date:  2020-08-27       Impact factor: 12.767

3.  Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.

Authors:  Michael S Saag; Constance A Benson; Rajesh T Gandhi; Jennifer F Hoy; Raphael J Landovitz; Michael J Mugavero; Paul E Sax; Davey M Smith; Melanie A Thompson; Susan P Buchbinder; Carlos Del Rio; Joseph J Eron; Gerd Fätkenheuer; Huldrych F Günthard; Jean-Michel Molina; Donna M Jacobsen; Paul A Volberding
Journal:  JAMA       Date:  2018-07-24       Impact factor: 56.272

4.  Beyond the Biomedical: Preexposure Prophylaxis Failures in a Cohort of Young Black Men Who Have Sex With Men in Atlanta, Georgia.

Authors:  David P Serota; Eli S Rosenberg; Annie M Lockard; Charlotte-Paige M Rolle; Nicole Luisi; Scott Cutro; Carlos Del Rio; Aaron J Siegler; Travis H Sanchez; Patrick S Sullivan; Colleen F Kelley
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

5.  Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection.

Authors:  Susan H Eshleman; Estelle Piwowar-Manning; Mariya V Sivay; Barbara Debevec; Stephanie Veater; Laura McKinstry; Linda-Gail Bekker; Sharon Mannheimer; Robert M Grant; Margaret A Chesney; Thomas J Coates; Beryl A Koblin; Jessica M Fogel
Journal:  J Clin Virol       Date:  2018-01-11       Impact factor: 3.168

6.  Uptake and impact of facility-based HIV self-testing on PrEP delivery: a pilot study among young women in Kisumu, Kenya.

Authors:  Valentine Wanga; Victor Omollo; Elizabeth A Bukusi; Josephine B Odoyo; Jennifer F Morton; Lara Kidoguchi; Rachel Johnson; James P Hughes; Connie Celum; Jared M Baeten
Journal:  J Int AIDS Soc       Date:  2020-08       Impact factor: 5.396

7.  HIV rapid screening tests and self-tests: Be aware of differences in performance and cautious of vendors.

Authors:  Thomas Mourez; Véronique Lemée; Valérie Delbos; Constance Delaugerre; Elodie Alessandri-Gradt; Manuel Etienne; François Simon; Marie-Laure Chaix; Jean-Christophe Plantier
Journal:  EBioMedicine       Date:  2018-10-24       Impact factor: 8.143

Review 8.  Primary HIV Infection: Clinical Presentation, Testing, and Treatment.

Authors:  Aurélia Henn; Clara Flateau; Sébastien Gallien
Journal:  Curr Infect Dis Rep       Date:  2017-09-07       Impact factor: 3.663

9.  Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation.

Authors:  Trevor A Crowell; Justin Ritz; Robert W Coombs; Lu Zheng; Joseph J Eron; John W Mellors; Joan Dragavon; Gert U van Zyl; Javier R Lama; Kiat Ruxrungtham; Beatriz Grinsztejn; Roberto C Arduino; Lawrence Fox; Jintanat Ananworanich; Eric S Daar
Journal:  Clin Infect Dis       Date:  2021-08-02       Impact factor: 20.999

10.  Immediate PrEP after PEP: Results from an Observational Nurse-Led PEP2PrEP Study.

Authors:  Patrick O'Byrne; Lauren Orser; Amanda Vandyk
Journal:  J Int Assoc Provid AIDS Care       Date:  2020 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.